28 September 2017 | News
The dialogue aims to strengthen scientific, regulatory, and health cooperation between the two nations and the global community.
The second India-United States health dialogue ended recently in New Delhi after discussions on communicable and non-communicable diseases, health systems, biomedical research and low-cost innovations, science and health data, food and drug regulations, traditional medicine and access to medicines.
The US delegation visited several institutes in New Delhi, Mumbai, and Bengaluru to see collaborations to control and manage HIV/AIDS, tuberculosis, antimicrobial resistance, cancer, acute encephalitis syndrome, mental health, vision and traditional medicine.
The dialogue aims to strengthen scientific, regulatory, and health cooperation between the two nations and the global community; highlight priorities and ongoing activities, and exchange information on policies, regulations, research, technologies, programs, activities, and practices.
C.K. Mishra, secretary, ministry of health & family welfare stated that it is mutually beneficial for India and the US to continue to engage on health issues, to not only address our health challenges but to also, in the process, contribute to global health objectives and outcomes. The goal is to facilitate the development of new collaborations.